Buy Or Sell Opportunity • Apr 09
Now 34% overvalued The stock has been flat over the last 90 days, currently trading at S$0.028. The fair value is estimated to be S$0.021, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Buy Or Sell Opportunity • Mar 21
Now 29% overvalued Over the last 90 days, the stock has fallen 3.6% to S$0.027. The fair value is estimated to be S$0.021, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. New Risk • Mar 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Singaporean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (S$22.5m market cap, or US$17.5m). Buy Or Sell Opportunity • Mar 06
Now 29% overvalued after recent price rise Over the last 90 days, the stock has risen 3.8% to S$0.027. The fair value is estimated to be S$0.021, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Reported Earnings • Jan 14
Full year 2025 earnings released: EPS: S$0.001 (vs S$0.001 in FY 2024) Full year 2025 results: EPS: S$0.001 (in line with FY 2024). Revenue: S$7.94m (down 39% from FY 2024). Net income: S$616.0k (up 19% from FY 2024). Profit margin: 7.8% (up from 4.0% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Duyuru • Jan 13
Amplefield Limited, Annual General Meeting, Jan 28, 2026 Amplefield Limited, Annual General Meeting, Jan 28, 2026, at 14:00 Singapore Standard Time. Location: relc international hotel, room 503, level 5, 30 orange grove road, singapore 258352, Singapore Reported Earnings • Nov 28
Full year 2025 earnings released Full year 2025 results: Revenue: S$8.36m (down 35% from FY 2024). Net income: S$616.0k (up 19% from FY 2024). Profit margin: 7.4% (up from 4.0% in FY 2024). The increase in margin was driven by lower expenses. New Risk • Nov 25
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported March 2025 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (S$21.6m market cap, or US$16.5m). Buy Or Sell Opportunity • Aug 22
Now 25% overvalued after recent price rise Over the last 90 days, the stock has risen 10.0% to S$0.022. The fair value is estimated to be S$0.018, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.7% over the last 3 years. Meanwhile, the company has become profitable. Board Change • Jan 24
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 3 highly experienced directors. Executive Vice Chairman of the Board Teiong Yap was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Duyuru • Jan 22
Amplefield Limited Announces Board and Committee Changes Amplefield Limited announced re-designation of Albert Saychuan Cheok as Non-Executive Non-Independent Chairman and Member of Audit Committee. Job Title: Independent Chairman, Chairman of AC and Member of RC and NC (prior to the re-designation disclosed in this announcement). Other DirectorShips Past: Peppermint Innovation Ltd, 5G Networks Limited and MC Payment Limited. Other DirectorShips Present: China Aircraft Leasing Group Holdings Ltd, Supermax Corporation Berhad and Forbidden Foods Limited. Reason For Cessation: Mr. Albert Saychuan Cheok has been an Independent Director of the Company for an aggregate period of more than nine years. Pursuant to Rule 406(3)(d)(iv) of the Listing Manual Section B: Rules of Catalist of the Singapore Exchange Securities Trading Limited (the "Catalist Rules"), Mr. Cheok is no longer eligible to be designated as an Independent Director of the Company and has been re-designated as the Non-Executive Non-Independent Chairman of the Company following the conclusion of the annual general meeting of the Company held on 22 January 2025 ("AGM"). Upon recommendation of the Nominating Committee ("NC"), the Board has determined that Mr. Cheok 's continued involvement as the Non-Executive Non-Independent Chairman would be highly beneficial for the Company and its shareholders, by providing continuity, valuable insight, and expertise that supports the Company's long-term strategy and governance. As such, the Board approved the re-designation of Mr. Cheok from the Independent Chairman to the Non-Executive Non-Independent Chairman. Mr. Cheok has also stepped down from his role as the Chairman of the Audit Committee ("AC") and continues to serve as a member of the NC, AC and Remuneration Committee ("RC") of the Company after the conclusion of the AGM. The Board considers Mr. Cheok to be non-independent for the purposes of Rule 704(7) of the Catalist Rules. Mr. Cheok had abstained from the deliberations and decision-making in relation to his re-designation. After having interviewed Mr. Cheok and to the best of its knowledge, the Sponsor is satisfied that save as disclosed in this announcement, there are no other material reasons for the re-designation of Mr. Cheok as the Non-Executive Non-Independent Chairman of the Company. Announcement Date is January 22, 2025. Mr. Albert Saychuan Cheok, the Non-Executive Non-Independent Chairman of the Company, will step down as the Chairman of the AC and be appointed as a member of the AC. He will remain as a member of the RC and NC; and Mr. Chong Teik Siang, an Independent Director of the Company, be appointed as the Lead Independent Director and the Chairman of the AC. He will remain as the Chairman of the NC and a member of the RC. Consequent to the aforesaid changes, the composition of the Board and Board Committees shall be as follows: Board of Directors: Mr. Albert Saychuan Cheok – Non-Executive Non-Independent Chairman; Dato' Sri Yap Teiong Choon – Executive Vice Chairman; Mr. Yap Weng Yau – Executive Director; Mr. Woon Ooi Jin – Executive Director; Mr. Chong Teik Siang – Lead Independent Director and Mr. Teh Leong Kok – Independent Non-Executive Director. Audit Committee: Mr. Chong Teik Siang – Chairman; Mr. Albert Saychuan Cheok – Member and Mr. Teh Leong Kok – Member. Remuneration Committee: Mr. Teh Leong Kok – Chairman; Mr. Chong Teik Siang – Member and Mr. Albert Saychuan Cheok – Member. Nominating Committee: Mr. Chong Teik Siang – Chairman; Mr. Albert Saychuan Cheok – Member and Mr. Teh Leong Kok – Member. New Risk • Jan 09
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 46% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (15% average weekly change). Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (S$17.1m market cap, or US$12.5m). Duyuru • Jan 08
Amplefield Limited Announces Retirement of Ling Chung Yee as Independent Director Amplefield Limited announced the retirement of Prof. Ling Chung Yee as Independent Director. Role And Responsibilities: Non-Executive. Job Title: Independent Director, Member of Audit Committee, Remuneration Committee and Nominating Committee. Other DirectorShips Past: Ley Choon Group Holdings Ltd., Debao Property Development Ltd., Vingroup JSC and Sino Grandness Food Industry Group Ltd. Other DirectorShips Present: Advanced Systems Automation Ltd., Memiontec Holdings Ltd., Combine Will International Holdings Ltd., CASE Endowment Fund Governing Board, VinFast Auto Ltd., FollowTrade Pte. Ltd. and United Food Holdings Ltd. Reason For Cessation: To pursue other professional commitments, Prof. Ling Chung Yee (‘Prof. Ling’) will be retiring from office upon the conclusion of forthcoming Annual General Meeting held on 22 January 2025. He will concurrently relinquish his position as a member of the Remuneration Committee, Audit Committee and Nominating Committee of the Company. There is no notice period for Prof. Ling's retirement. Duyuru • Jan 07
Amplefield Limited, Annual General Meeting, Jan 22, 2025 Amplefield Limited, Annual General Meeting, Jan 22, 2025, at 14:00 Singapore Standard Time. Location: relc international hotel, room 503, level 5, 30 orange grove road, singapore 258352, Singapore Reported Earnings • Dec 14
Full year 2024 earnings released Full year 2024 results: Revenue: S$13.6m (up 58% from FY 2023). Net income: S$516.0k (up S$2.21m from FY 2023). Profit margin: 3.8% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. New Risk • Nov 29
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 62% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Market cap is less than US$100m (S$16.2m market cap, or US$12.0m). Duyuru • Sep 27
Amplefield Limited Announces Resignation of Phan Chee Shong as Executive Director, Effective September 30, 2024 Amplefield Limited announced resignation that Mr. Phan Chee Shong has on 26 September 2024 tendered his resignation with effect from 30 September to ensure the Board has a better mix of Executive and Non-executive Directors. Following his resignation, Mr. Phan will remain as an Executive Officer of the Company. Familial RelationShip: Brother of Substantial Shareholder, Phan Foo Beam, the brother-in-law of Dato' Sri Yap Teiong Choon, Executive Vice Chairman and uncle of Yap Weng Yau, the Executive Director. Other DirectorShips Past: Niche Properties Sdn. Bhd. Buy Or Sell Opportunity • Feb 20
Now 55% overvalued The stock has been flat over the last 90 days, currently trading at S$0.019. The fair value is estimated to be S$0.012, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 45% over the last 3 years. Meanwhile, the company became loss making. New Risk • Feb 16
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: S$12.6m (US$9.34m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 70% per year over the past 5 years. Market cap is less than US$10m (S$12.6m market cap, or US$9.34m). Board Change • Feb 05
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Executive Vice Chairman of the Board Teiong Yap was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Jan 11
Full year 2023 earnings released: S$0.002 loss per share (vs S$0.006 loss in FY 2022) Full year 2023 results: S$0.002 loss per share (improved from S$0.006 loss in FY 2022). Revenue: S$8.62m (down 29% from FY 2022). Net loss: S$1.70m (loss narrowed 68% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance. Duyuru • Jan 10
Amplefield Limited, Annual General Meeting, Jan 25, 2024 Amplefield Limited, Annual General Meeting, Jan 25, 2024, at 14:00 Singapore Standard Time. Location: RELC International Hotel, Room 506, Level 5, 30 Orange Grove Road, Singapore 258352 Singapore Singapore Agenda: To consider Adoption of the Directors' Statement, Audited Financial Statements and Independent Auditors' Report for the financial year ended 30 September 2023; to consider Re-election of Mr Albert Saychuan Cheok as a Director of the Company; to consider Re-election of Dato' Sri Yap Teiong Choon as a Director of the Company; to consider Re-election of Mr Phan Chee Shong as a Director of the Company; to consider Approval of Directors' fees amounting to S$104,000 for the financial year ended 30 September 2023 (FY2022: S$100,000);to consider Re-appointment of Lo Hock Ling & Co. as auditors of the Company and to authorise Directors to fix their remuneration; and to transact such other business matters. Board Change • Dec 20
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Executive Vice Chairman of the Board Sri Yap Choon was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 30
Full year 2023 earnings released Full year 2023 results: Revenue: S$10.1m (down 17% from FY 2022). Net loss: S$1.70m (loss narrowed 68% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 124 percentage points per year, which is a significant difference in performance. Board Change • Oct 27
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Executive Vice Chairman of the Board Sri Yap Choon was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Sep 26
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Executive Vice Chairman of the Board Sri Yap Choon was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Sep 12
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Executive Vice Chairman of the Board Sri Yap Choon was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. New Risk • Aug 19
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Singaporean stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 68% per year over the past 5 years. Minor Risk Market cap is less than US$100m (S$18.9m market cap, or US$13.9m). Reported Earnings • May 17
First half 2023 earnings released First half 2023 results: Revenue: S$3.59m (down 53% from 1H 2022). Net income: S$127.0k (down 66% from 1H 2022). Profit margin: 3.5% (down from 4.8% in 1H 2022). Reported Earnings • Dec 31
Full year 2022 earnings released: S$0.006 loss per share (vs S$0 in FY 2021) Full year 2022 results: S$0.006 loss per share (further deteriorated from S$0 in FY 2021). Revenue: S$12.2m (up 292% from FY 2021). Net loss: S$5.35m (down S$5.75m from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 122 percentage points per year, which is a significant difference in performance. Duyuru • Dec 31
Amplefield Limited, Annual General Meeting, Jan 17, 2023 Amplefield Limited, Annual General Meeting, Jan 17, 2023, at 14:00 Singapore Standard Time. Agenda: To consider adoption of the Directors' Statement, Audited Financial Statements and Independent Auditors' Report for the financial year ended 30 September 2022; to consider board changes; to consider re-appointment of Lo Hock Ling & Co. as auditors of the Company; and to consider other matters. Board Change • Nov 16
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Executive Vice Chairman of the Board Sri Yap Choon was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • May 04
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Executive Vice Chairman of the Board Sri Yap Choon was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Apr 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Executive Vice Chairman of the Board Sri Yap Choon was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Executive Departure • Feb 17
Company Secretary has left the company On the 15th of February, Guat Chua's tenure as Company Secretary ended after less than a year in the role. We don't have any record of a personal shareholding under Guat's name. A total of 2 executives have left over the last 12 months. Duyuru • Feb 16
Amplefield Limited Announces Executive Changes Amplefield Limited announced that Ms. Lee Pih Peng will be appointed as Secretary of the company in place of Ms. Helena Chua Guat Huat, effective February 15, 2021 and will hold office until otherwise resolved. Duyuru • Jan 07
Amplefield Limited, Annual General Meeting, Jan 22, 2021 Amplefield Limited, Annual General Meeting, Jan 22, 2021, at 14:00 Singapore Standard Time. Agenda: To consider adoption of the Directors' statement, audited financial statements and Independent Auditors' Report for the financial year ended 30 September 2020; to consider re-election of Yap Weng Yau as a Director of the company; to consider re-election of Woon Ooi Jin as a Director of the company; to consider re-election of Albert Saychuan Cheok as a Director of the company; to consider approval of Directors' fees amounting to SGD 83,600 for the financial year ended 30 September 2020 (FY2019: SGD 77,945) ; to consider re-appointment of Lo Hock Ling & Co. as auditors of the company and to authorize Directors to fix their remuneration; to consider continuing in office as Independent Non-Executive Director Mr. Albert Saychuan Cheok (Tier 1 Voting) and (Tier 2 Voting); to consider authority to allot and issue shares; to consider proposed renewal of the Share Buyback Mandate; and to consider proposed renewal of the shareholders' mandate for Interested Person Transactions. Duyuru • Aug 06
Amplefield Limited (Catalist:AOF) completed the acquisition of 40% stake in CAM Mechatronic (Philippines) Inc. from CMP Mechatronics Inc. Amplefield Limited (Catalist:AOF) entered into a sale and purchase agreement to acquire 40% stake in CAM Mechatronic (Philippines) Inc. from CMP Mechatronics Inc. for SGD 2 million on July 14, 2020. Under the terms of the agreement, Amplefield will acquire 19.2 million shares. Amplefield has agreed with CMP Mechatronics that the outstanding amount of approximately SGD 1.75 million owing by CMP Mechatronics to Amplefield shall be set off against the consideration, in partial settlement and satisfaction of the consideration payable by Amplefield. The balance of the consideration of approximately SGD 0.25 million will be payable in cash on such date or dates to be mutually agreed. Upon completion of the transaction, CAM Mechatronic (Philippines) Inc. will become a 40%-owned associated company of Amplefield Limited while CMP Mechatronics Inc. will own 59.99% of CAM Mechatronic (Philippines) Inc. CAM Mechatronic (Philippines) had net asset value of SGD 1.32 million as at September 30, 2019. The transaction is not expected to have any material impact on the earnings per share and the net tangible assets per share of Amplefield for year 2020.
Amplefield Limited (Catalist:AOF) completed the acquisition of 40% stake in CAM Mechatronic (Philippines) Inc. from CMP Mechatronics Inc. on July 31, 2020. Duyuru • Jul 17
Amplefield Limited (Catalist:AOF) entered into a sale and purchase agreement to acquire 40% stake in CAM Mechatronic (Philippines) Inc. from CMP Mechatronics Inc. for SGD 2 million. Amplefield Limited (Catalist:AOF) entered into a sale and purchase agreement to acquire 40% stake in CAM Mechatronic (Philippines) Inc. from CMP Mechatronics Inc. for SGD 2 million on July 14, 2020. Under the terms of the agreement, Amplefield will acquire 19.2 million shares. Amplefield has agreed with CMP Mechatronics that the outstanding amount of approximately SGD 1.8 million owing by CMP Mechatronics to Amplefield shall be set off against the consideration, in partial settlement and satisfaction of the consideration payable by Amplefield. The balance of the consideration of approximately SGD 0.25 million will be payable in cash on such date or dates to be mutually agreed. CAM Mechatronic (Philippines) had net asset value of SGD 1.32 million as at September 30, 2019. The transaction is not expected to have any material impact on the earnings per share and he net tangible assets per share of Amplefield for year 2020.